Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mirela Gherman-Caprioara"'
Publikováno v:
Clujul Medical
Background and aims. Arterial stiffness seems to be influenced by the dialysis method, but studies are sparse and the results discordant. High substitution volume online hemodiafiltration appears to have beneficial cardiovascular effects in dialysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6fc6b2debd6bd8095a62753f2e62c18
https://doi.org/10.15386/cjmed-699
https://doi.org/10.15386/cjmed-699
Autor:
Alina Potra, Ina Maria Kacso, Diana Moldovan, Crina Rusu, Ioan Mihai Patiu, Mirela Gherman-Caprioara, Ioan Moldovan
Publikováno v:
International Urology and Nephrology. 49:895-901
Osteoprotegerin (OPG) is a powerful inhibitor of osteoclast activity, and it plays an important role in bone metabolism. In hemodialysis (HD) patients, the relationship between OPG and bone mineral density (BMD) is important, but remains unclear yet.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1229f016c97c10cf22ff29fc44084bdc
https://doi.org/10.1007/s11255-017-1529-7
https://doi.org/10.1007/s11255-017-1529-7
Autor:
Diana Moldovan, Mirela Gherman Caprioara, Dan Vladutiu, Crina Rusu, Ioan Mihai Patiu, Alina Potra, Simona Racasan, Ina Maria Kacso
Publikováno v:
Clujul Medical
Background and aims. Cardiovascular (CV) disease is the leading cause of morbidity and mortality in hemodialysis (HD) patients. Kidney disease is associated with increased oxidative stress (OS), a nontraditional CV risk factor. Few studies evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8882ec94d2109131c0add0d65ab2c239
http://europepmc.org/articles/PMC4849384
http://europepmc.org/articles/PMC4849384
Autor:
Ina Maria Kacso, Alina Potra, Crina Rusu, Ioan Mihai Patiu, Mirela Gherman-Caprioara, Diana Moldovan
Publikováno v:
Clujul Medical
Background and aim. In spite of numerous interventions, the control of mineral disturbances remains poor in end-stage renal failure (ESRF) patients. Chronic kidney disease - mineral and bone disorders (CKD-MBD) represent an important cause of mortali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4356f675ac3599c598ecbda66b82d25
https://doi.org/10.15386/cjmed-515
https://doi.org/10.15386/cjmed-515
Autor:
Ioan Mihai Patiu, Simona Racasan, Ina Maria Kacso, Crina Rusu, Mirela Gherman-Caprioara, Cosmina Ioana Bondor, Diana Moldovan, Alina Potra
Publikováno v:
International Urology and Nephrology. 47:1871-1877
The life for end-stage renal disease patients has remarkably improved in the last years. Although mineral and bone disorders remain as unsolved complication, in severe secondary hyperparathyroidism (sHPT), the ultimate treatment is parathyroidectomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40359904f9f4cecd94d2a10b7741805f
https://doi.org/10.1007/s11255-015-1106-x
https://doi.org/10.1007/s11255-015-1106-x
Autor:
Ioan Moldovan, Ioan Mihai Patiu, Dan Vladutiu, Alina Potra, Ina Maria Kacso, Crina Rusu, Cosmina Ioana Bondor, Mirela Gherman Caprioara, Diana Moldovan
Publikováno v:
Biomarkers. 20:116-122
Aim: To assess the osteoprotegerin (OPG) relationship with cardiovascular complications in hemodialysis (HD) patients.Methods: The study included 87 HD patients. Clinical characteristics, ankle-arm index (AAI), OPG and mineral markers levels were rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a483f698f93f790c0691fa6778b50723
https://doi.org/10.3109/1354750x.2014.1000376
https://doi.org/10.3109/1354750x.2014.1000376
Publikováno v:
Therapeutic Apheresis and Dialysis. 19:119-124
Aberrant DNA methylation is an emerging characteristic of chronic kidney disease including dialysis patients. It appears to be associated to inflammation. We compared the global DNA methylation status in 10 control subjects compared to 80 dialysis pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66b95b4eab2c898e0a5abb500c55988f
https://doi.org/10.1111/1744-9987.12238
https://doi.org/10.1111/1744-9987.12238
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 21, Iss 4, Pp 399-406 (2013)
Obiectiv. La pacienţii cu diabet zaharat de tip 2, natura progresivă a afectării renale reprezintă un risc crescut de mobiditate şi mortalitate. Scopul studiului nostru a fost acela de a evalua valoarea predictivă a molecului de adeziune interc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127589512356404382e016dff0b7f0d6
https://doaj.org/article/950f07fc116445619c3b1bf7087bf97a
https://doaj.org/article/950f07fc116445619c3b1bf7087bf97a
Autor:
Ina Maria Kacso, Ioan Moldovan, Crina Rusu, Ioan Mihai Patiu, Mirela Gherman-Caprioara, Diana Moldovan
Publikováno v:
International Urology and Nephrology. 46:121-128
Chronic hemodialysis (HD) patients have bad prognosis and cardiovascular diseases (CVD) represent their main threatening complication. Fibroblast growth factor (FGF-23) has been associated with all kinds of evil consequences, including cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda9a0027541eb97edfdcffe5e1c960b
https://doi.org/10.1007/s11255-013-0422-2
https://doi.org/10.1007/s11255-013-0422-2
Autor:
Mirela Gherman Caprioara, Dan Vladutiu, Dacian Tirinescu, Simona Racasan, Cosmina Ioana Bondor, Diana Moldovan, Alina Potra, Crina Rusu, Ina Maria Kacso, Ioan Mihai Patiu, Cristian Budurea, Remus Orasan
Publikováno v:
International urology and nephrology. 49(3)
Finding new, reliable biomarkers of cardiovascular risk in hemodialysis (HD) patients is of utmost importance. Fibroblast growth factor 21 (FGF21) has been recently associated with atherosclerosis in the general population. The relationship between m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad699865321ddfc08836c0f31fd77a59
https://pubmed.ncbi.nlm.nih.gov/27943169
https://pubmed.ncbi.nlm.nih.gov/27943169